virginia catalyst
  • Home
  • Grant Funding
    • Apply for Funding
    • History of Awards
    • Downloads
  • News
  • About
    • Our Team
    • Contact Us
    • Terms & Conditions
    • Privacy
  • Home
  • Grant Funding
    • Apply for Funding
    • History of Awards
    • Downloads
  • News
  • About
    • Our Team
    • Contact Us
    • Terms & Conditions
    • Privacy
901 E. Cary Street
Suite 900
Richmond, Virginia

(804) 545-5799

Virginia Catalyst Announces Grant Round 14 Awarded Projects

5/18/2023

0 Comments

 
Virginia Catalyst Awards $2 Million in Grants to Support Life Sciences in the Commonwealth  Four collaborative projects involving Virginia research universities and industry partners selected to address major unmet healthcare needs, drive job creation and capital formation in Virginia
 
RICHMOND, VA – May 18, 2023  – The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $2 million in grants to four life and bioscience projects in the Commonwealth of Virginia, pending execution of the grant agreements. These grants, which will be met with significant matching funds from partner companies, were awarded through Grant Round 14 of Virginia Catalyst’s ongoing mission to stimulate economic development by promoting collaborative projects that address large, unmet needs for improving human health, and that can create high-paying jobs in the Commonwealth.

Read the full press release here
0 Comments

Virginia Catalyst Announces Grant Round 15

4/12/2023

0 Comments

 
RICHMOND, VA – April 12, 2023– The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it is accepting letters of intent (LOI) for Grant Round 15 to fund the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy.
 
“When you combine world class research with entrepreneurial management and capital, then stir, good things happen,” said Mike Grisham, CEO of Virginia Catalyst. “We are looking for passionate research scientists and entrepreneurial leaders in high-growth life science businesses in Virginia who could use $200,000 to $800,000 in non-dilutive grant funding to further a project that improves human health and advances economic development in the Commonwealth. Our Grant Round 15 is now open, and we strongly encourage interested parties to visit the Virginia Catalyst website and apply.”
 
Letters of Intent (LOI) must be received by June 20, 2023 at 5:00 PM EDT. Projects that meet funding criteria will be invited to submit a full application. Applications will be reviewed and scored by an independent review team of scientists, venture capitalists and CEOs of Virginia-based life science companies. The top eight applicant teams will be invited to present their proposal the week of September 25, 2023. Awards will be announced at the end of September 2023. The LOI submission form, along with funding criteria and frequently asked questions, are available on the Virginia Catalyst website (www.virginiacatalyst.org/apply.html).    

Read the full press release
0 Comments

Virginia Catalyst Announces Grant Round 13

12/9/2021

0 Comments

 
RICHMOND, VA – December 9, 2021– The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it is accepting letters of intent (LOI) for Grant Round 13 to fund the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy.
 
“When you combine world class research with entrepreneurial management and capital, then stir, good things happen,” said Mike Grisham, CEO of Virginia Catalyst. “We are looking for passionate research scientists and entrepreneurial leaders in high-growth life science businesses in Virginia who could use $200,000 to $800,000 in non-dilutive grant funding to further a project that improves human health and advances economic development in the Commonwealth. Our Grant Round 13 is now open, and we strongly encourage interested parties to visit the Virginia Catalyst website and apply.”

Read the full press release here
0 Comments

Virginia Catalyst Awards $1.9 Million from Grant Round 12

10/28/2021

0 Comments

 
RICHMOND, VA – October 28, 2021 – The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $1.9 million in grants to three life and bioscience projects in the Commonwealth of Virginia. These grants, which will be met with significant matching funds from partner companies, were awarded through Grant Round 12 of Virginia Catalyst’s ongoing mission to stimulate economic development by promoting collaborative projects that address large, unmet needs for improving human health, and that can create high-paying jobs in the Commonwealth.
 
“We are excited to continue our mission of supporting collaborations and fostering economic growth in Virginia’s life sciences, enabling the Commonwealth to compete on a national and global scale,” said Mike Grisham, CEO, Virginia Catalyst. “The critical mass achieved by these collaborations provides Virginia with competitive advantages over other states and has resulted in significant outside capital being invested to finance the commercialization of Virginia’s innovations and create significant high-paying jobs for the Commonwealth.”
 
Through this 12th round of funding, Virginia Catalyst has awarded 49 grants totaling $24 million, resulting in over $44 million in matching funds and an additional $250 million in follow-on funding to date.

Click here to read the press release
0 Comments

Virginia Catalyst Announces Opening of Grant Round 12

3/30/2021

 
.
RICHMOND, VA – March 30, 2021– The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it is accepting letters of intent (LOI) for Grant Round 12 to fund the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy.
Virginia Catalyst awards these funds to help accelerate translational research and the commercialization of Virginia’s innovations. The awards, which range from $200,000 to $800,000, help fund collaborative efforts between industry and Virginia research universities.
​Letters of Intent (LOI) must be received by June 15, 2021 at 5:00 PM EDT. Projects that meet criteria will be invited to submit a full application by July 22, 2021. Applications will be reviewed and scored by an independent review team of scientists, venture capitalists and CEOs of Virginia-based life science companies. The top eight applicant teams will be invited to virtually present their proposal on Wednesday, September 8, 2021. Awards will be announced at the end of September 2021. The LOI submission form, along with funding criteria and frequently asked questions, are available on the Virginia Catalyst website (www.virginiacatalyst.org/apply.html). 

Read the full press release here

Virginia Catalyst Announces COVID-19 Grant Funding

1/28/2021

0 Comments

 
RICHMOND, VA – January 28, 2021  – The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it is conducting a formalized, competitive, one-time COVID-19 Therapeutic Drug Grant Funding Round of up to $5,000,000 to:
  • Support the acceleration of clinical testing by one or more Virginia companies of a therapeutic drug that treats life-threatening symptoms caused by COVID-19
  • Encourage collaborative partnerships between investigators at one or more Virginia research universities and each grant recipient
  • Increase Virginia’s national and global competitiveness in the life sciences by creating critical mass through collaborations between and among Virginia’s research universities and industry partners
  • Create investment or jobs in Virginia
The Catalyst is now accepting applications for this special COVID-19 Grant Round.

Learn more about the: Funding Criteria for COVID-19 Grant Round

Read the full press release
0 Comments

Virginia Catalyst Announces $2.1 Million Awarded

10/26/2020

0 Comments

 
RICHMOND, VA – October 26, 2020 – The Virginia Catalyst today announced that it has awarded $2.1 million in grants to three life and bioscience projects in the Commonwealth of Virginia. These grants, which will be met with significant matching funds from partner companies, were awarded as Round 11 of Virginia Catalyst’s ongoing mission to stimulate economic development by promoting collaborative projects that address large, unmet needs for improving human health, and that can create high-paying jobs in the Commonwealth.

Round 11 of grant funding project winners:
Project: Clinical Translation of a Male Contraceptive Procedure
  • Company: Contraline, Inc. (Charlottesville, VA)
  • University collaborators: University of Virginia and Virginia Commonwealth University
  • Funding amount: $600,000
Project: Treating chronic Disease Caused by Microbiome Dysbiosis
  • Company: ISOThrive, Inc. (Manassas, VA)
  • University collaborators: George Mason University, Eastern Virginia Medical School, and University of Virginia
  • Funding amount: $800,000
Project: Innovative Bioanalytical Instrument for Improving Drug Discovery
  • Company: Meru Biotechnologies (Richmond, VA)
  • University collaborators: Virginia Commonwealth University and Old Dominion University
  • Funding amount: $700,000
Read the full press release here
0 Comments

Special Announcement - Free Webinar April 22

4/9/2020

0 Comments

 
The Virginia Catalyst will host a free webinar in conjunction with Virginia Bio:
“Funding for Virginia Public-Private Biotech Partnerships…Come Learn How to Score and Win!”
 Wednesday, April 22      Noon – 1:00 pm
Join us on Zoom at:      https://zoom.us/j/644376195

Panel members include:
Mike Grisham, President and CEO of Virginia Catalyst
Mickey Kim, former Senior Vice President, Research and Commercialization, Inova Translational Medicine Institute, Inova Health System
J
ames Powers, Chairman and CEO, HemoShear Theapeutics, LLC
Thomas D. Roberts III, General Partner, Harbert Growth Partners, Harbert Management Corporation

Topics include:  
Timeline and how to apply for Virginia Catalyst Grant Round 11
How to score highly, get funding and position your company and research university for significant follow-on funding from large corporations, venture capitalists, DARPA, NIH and philanthropic foundations
​

Read the full press release here ​
0 Comments

Virginia Catalyst Announces Opening of Grant Round 11

4/1/2020

0 Comments

 

Emphasis will be placed on Innovative Projects Focused on Solutions for COVID-19 and other Infectious Disease

RICHMOND, VA – April 1, 2020 – The Virginia Catalyst, formerly known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it is accepting letters of intent (LOI) for Grant Round 11 to fund the development and commercialization of life science projects that address major unmet needs for improving human health and advancing Virginia’s economy.
 
While all life science projects will be accepted for Grant Round 11, given the impact of COVID-19, emphasis will be placed on projects within the areas of infectious disease, immunology, vaccine and drug discovery, and innovative service delivery models including telehealth and telemedicine.

Read the full article here
0 Comments

Virginia Catalyst Announces Grant Round 9 Awarded Projects

6/4/2019

0 Comments

 
RICHMOND, VA – June 4, 2019 – The Virginia Catalyst, formerly known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $2.1 million in grants to four life and bioscience projects in the Commonwealth of Virginia. These grants, which will be met with nearly $3.2 million in matching funds from partner companies, were awarded as Round 9 of Virginia Catalyst’s ongoing mission to stimulate economic development by promoting collaborative projects that address large, unmet needs for improving human health, and that can create high-paying jobs in the Commonwealth.

“As national and global leaders in life sciences, Virginia’s research universities continue to foster collaborations, to combine their intellectual and scientific expertise with industry to achieve meaningful results,” said Mike Grisham, CEO, Virginia Catalyst. “We are excited to continue our mission of supporting collaborations in Virginia’s biosciences. The critical mass achieved by these collaborations provides Virginia with competitive advantages over other states and has resulted in significant outside capital being invested in Virginia to finance the commercialization of Virginia’s innovations, while creating high-paying jobs for the Commonwealth.”
 
Through this ninth round of funding, Virginia Catalyst has awarded 31 grants totaling over $15.9 million, resulting in a combined $33.4 million in matching funds and an additional $138 million in follow-on funding.  

​Read the full press release.
0 Comments
<<Previous

      Subscribe to our Newsletter

    Subscribe

    Archives

    May 2023
    April 2023
    December 2021
    October 2021
    March 2021
    January 2021
    October 2020
    April 2020
    June 2019
    April 2019
    January 2019
    August 2018
    July 2018
    May 2018
    February 2018
    December 2017
    September 2017
    July 2017
    June 2017
    April 2017
    September 2015
    August 2015
    April 2015

    Categories

    All

    RSS Feed

Home
Terms & Conditions
​Privacy
Picture
Contact Us
Mike Grisham, CEO
(804) 543-5200
[email protected]
  • Home
  • Grant Funding
    • Apply for Funding
    • History of Awards
    • Downloads
  • News
  • About
    • Our Team
    • Contact Us
    • Terms & Conditions
    • Privacy